Enovis Corporation

Enovis Corporation

ENOV·NYSE

$21.56

-1.7%
HealthcareMedical - Devices

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.

At a Glance

Live Snapshot
Market Cap$1.24B
EPS-20.8600
P/E Ratio-1.03
Earnings Date08/06/2026
-35.85%
Return on Invested Capital
96%
3Y+1890.0%
5Y+5623.0%
10Y-1240.0%
-79.51%
Return on Equity
147%
3Y+20526.0%
5Y-6710.0%
10Y-1898.0%
-30.89%
Return on Assets
77%
3Y+9828.0%
5Y-5427.0%
10Y-1640.0%
Enovis Corporation

Enovis Corporation Management Team

ENOV · NYSE
MD

Mr. Damien McDonald

Chief Executive Officer

Born 1965(Age 61)
male
MD

Mr. Daniel A. Pryor

Executive Vice President of Strategy & Business Development

Compensation

$1,131,324

Born 1968(Age 58)
male
MD

Mr. Davide Visentin

President of Enovis International Surgical

male
MT

Mr. Tim Czartoski

President of U.S. Surgical and Global Product & Enabling Technologies

male
MP

Mr. Phillip Benjamin Berry

Senior Vice President & Chief Financial Officer

Compensation

$988,719

Born 1979(Age 47)
male
MP

Ms. Patricia A. Lang

Senior Vice President & Chief Human Resources Officer

Compensation

$896,341

Born 1959(Age 67)
female
MB

Mr. Bradley J. Tandy J.D.

Senior Vice President & Chief Legal Officer

Compensation

$874,354

Born 1959(Age 67)
male
KS

Katie Sweet

Vice President of Corporate Communication

MK

Mr. Kyle William Rose

Vice President of Investor Relations

male
MJ

Mr. John Kleckner

Vice President, Controller & Chief Accounting Officer

Born 1977(Age 49)
male
enov

Enovis Corporation Insider Positioning

ENOV · NYSE

During the last 12 months, insiders have purchased $901K and sold $43K worth of ENOV shares, resulting in $857K of net buying activity.

3 Months

Bought

4.5K

105.52K

Sold

0

0.00

Net Activity

+106K

+$106K

3-6 Months

Bought

2.3K

56.55K

Sold

666

18.12K

Net Activity

+38K

+$38K

6-9 Months

Bought

8.9K

274.80K

Sold

0

0.00

Net Activity

+275K

+$275K

9-12 Months

Bought

15.7K

463.79K

Sold

958

25.35K

Net Activity

+438K

+$438K

Top Buyers

1
PDA

Pryor Daniel A

Officer: Evp, Strategy & Business Dev.

10.0K shares1 transactions

$289K

2
MD

Mcdonald Damien

Director, Officer: Chief Executive Officer

6.5K shares1 transactions

$200K

3
EO

Engert Oliver

Officer: Chief Administrative Officer

6.8K shares8 transactions

$162K

4
TBJ

Tandy Bradley J

Officer: Svp And Chief Legal Officer

3.2K shares1 transactions

$101K

5
KJ

Kleckner John

Officer: Principal Accounting Officer

2.5K shares1 transactions

$75K

Top Sellers

1
PDA

Pryor Daniel A

Other: Former Evp, Strategy & Bus Dev

666 shares1 transactions

$18K

2
VL

Vogt Louis

Officer: Group President, Recon

460 shares1 transactions

$12K

3
RTD

Ross Terry D

Officer: Group President, P&R

325 shares1 transactions

$9K

4
KJ

Kleckner John

Officer: Principal Accounting Officer

173 shares1 transactions

$5K

Insider Activity Analysis

Net Insider Sentiment

Bullish

Strong bullish signal with $857K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.

Buy/Sell Ratio

20.72:1

Exceptional buy/sell ratio. Buying dramatically outweighs selling—one of the strongest possible insider signals.

Recent Trend (3 Months)

$106K

Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.

Insider Participation

Moderate Buying

5 insider buyers vs. 4 sellers. More insiders buying than selling indicates positive sentiment.

Insider Activity Insight

Strong confluence of bullish signals: High buy/sell ratio, multiple insiders participating, and recent buying momentum all point to significant insider confidence. This level of coordinated buying often precedes positive developments.

SEC Filings

ENOV - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
DEF 14A

DEF 14A 2026

N/A

April 06, 2026
April 06, 2026
2026
DEF 14A

DEF 14A 2025

N/A

April 11, 2025
May 21, 2025
2025
DEF 14A

DEF 14A 2024

N/A

April 05, 2024
May 20, 2024
2024
DEF 14A

DEF 14A

N/A

March 31, 2023
March 31, 2023
 
DEF 14A

DEF 14A 2022

N/A

April 28, 2022
June 07, 2022
2022
DEF 14A

DEF 14A 2022

N/A

January 18, 2022
February 28, 2022
2022
DEF 14A

DEF 14A 2021

N/A

April 01, 2021
May 12, 2021
2021
DEF 14A

DEF 14A 2020

N/A

April 09, 2020
May 21, 2020
2020
DEF 14A

DEF 14A 2019

N/A

April 02, 2019
May 13, 2019
2019
DEF 14A

DEF 14A 2018

N/A

April 05, 2018
April 05, 2018
2018
Showing 1 to 10 of 19 filings